Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
18.05. | VITURA HEALTH LIMITED: Flora JV acquires Heyday Medical Clinic | 1 | ASX | ||
11.05. | VITURA HEALTH LIMITED: Q3 FY2025 business update | - | ASX | ||
23.04. | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX | ||
22.04. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
10.04. | VITURA HEALTH LIMITED: Response to ASX Letter about Director Trading | 3 | ASX | ||
07.03. | VITURA HEALTH LIMITED: S&P DJI Announces March 2025 Quarterly Rebalance | - | ASX | ||
04.03. | VITURA HEALTH LIMITED: Change of Director's Interest Notice | 1 | ASX | ||
28.02. | VITURA HEALTH LIMITED: Change of Director's Interest Notice | 1 | ASX | ||
28.02. | VITURA HEALTH LIMITED: Investor webinar and presentation | 2 | ASX | ||
25.02. | VITURA HEALTH LIMITED: Change of Director's Interest Notice | - | ASX | ||
24.02. | VITURA HEALTH LIMITED: Cleansing Notice | - | ASX | ||
24.02. | VITURA HEALTH LIMITED: Application for quotation of securities - VIT | - | ASX | ||
24.02. | VITURA HEALTH LIMITED: Vitura completes acquisition of Canview platform | - | ASX | ||
24.02. | VITURA HEALTH LIMITED: H1 FY2025 financial results | - | ASX | ||
24.02. | VITURA HEALTH LIMITED: 2025 Half-Year Financial Report | - | ASX | ||
24.02. | VITURA HEALTH LIMITED: Appendix 4D | - | ASX | ||
20.02. | VITURA HEALTH LIMITED: Vitura completes acquisition of Candor Medical | 2 | ASX | ||
17.02. | VITURA HEALTH LIMITED: Update - Proposed issue of securities - VIT | - | ASX | ||
17.02. | VITURA HEALTH LIMITED: Becoming a substantial holder - updated | - | ASX | ||
14.02. | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
AURORA CANNABIS | 4,885 | +0,10 % | AURORA CANNABIS INC - 6-K, Report of foreign issuer | ||
TILRAY BRANDS | 0,360 | -0,28 % | THC Drinks Aren't The New Beer, They're Something Else, Says Tilray | ||
ORGANIGRAM GLOBAL | 1,180 | +0,85 % | Organigram Global Inc. reicht 6-K Bericht bei der SEC ein | ||
SNDL | 1,112 | -1,24 % | SNDL Inc.: SNDL Reports First Quarter 2025 Financial and Operational Results | The Company Delivers Record Gross Margin and Positive Cash Flow; Announces Strategic Review of U.S. Platform and Listing Structure
EDMONTON, AB, May 1, 2025 ... ► Artikel lesen | |
MYDECINE INNOVATIONS GROUP | 0,002 | +100,00 % | Mydecine Innovations Group Inc (2): Mydecine has no material changes | ||
BIONANO GENOMICS | 3,700 | 0,00 % | Bionano Genomics: Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress | SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2025. "The first quarter of 2025 represents... ► Artikel lesen | |
TONIX PHARMACEUTICALS | 36,000 | +5,26 % | Tonix Pharmaceuticals Holding Corp. - S-8, Securities to be offered to employees in employee benefit plans | ||
HIGH TIDE | 2,015 | -1,23 % | High Tide schafft mit der Eröffnung der 200. Canna Cabana-Filiale in Alberta einen wichtigen Meilenstein | CALGARY, AB, 29. Mai 2025 / IRW-Press / High Tide Inc. ("High Tide" oder das "Unternehmen") (Nasdaq: HITI) (TSXV: HITI) (FWB: 2LYA) - ein erfolgreiches, auf den
Einzelhandel ausgerichtetes Unternehmen... ► Artikel lesen | |
JAGUAR HEALTH | 3,940 | -5,52 % | Jaguar Health, Inc.: Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | SAN FRANCISCO, CA / ACCESS Newswire / May 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), today announced that it has entered into definitive agreements for the purchase and... ► Artikel lesen | |
GREENRISE GLOBAL BRANDS | 0,003 | 0,00 % | Greenrise Global Brands Inc: Greenrise Global hopes to file financials by June 30 | ||
ACHIEVE LIFE SCIENCES | 3,385 | +1,04 % | Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program | Reiterates Planned Submission of an NDA for Cytisinicline to FDA in June 2025 Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, May 13, 2025 SEATTLE and VANCOUVER, British Columbia, May... ► Artikel lesen | |
SEELOS THERAPEUTICS | 0,123 | -8,88 % | Delisting of Securities of Patria Latin American Opportunity Acquisition Corp.; Trevena, Inc.; Seelos Therapeutics, Inc.; DP Cap Acquisition Corp I; Chain Bridge I; Qomolangma Acquisition Corp.; Gaucho Group Holdings, Inc. ... | NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the Class A Ordinary Shares, unit, and warrant of Patria Latin American Opportunity Acquisition... ► Artikel lesen | |
PLANTFUEL LIFE | 0,009 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.03.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 24.03.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.03.2025ISIN NameCA12571Q4034 CMC... ► Artikel lesen | |
MEDIPHARM LABS | 0,045 | +0,90 % | MediPharm Labs Corp.: MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder | TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE:MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids... ► Artikel lesen | |
ARGENT BIOPHARMA | 0,048 | 0,00 % | Argent BioPharma Ltd. Updates on SINTEF Collaboration for Chronic Wound Management | Advanced wound care market projected to exceed $15 billion globally by 2030
PERTH, Australia, Feb. 12, 2025 /PRNewswire/ -- Argent BioPharma Ltd. (ASX: RGT)... ► Artikel lesen |